BLOG

RH
Ryan Hampton
|
August 01, 2023
The FDA also approved the first generic non-prescription naloxone drug in July 2023. The US Food and Drug Administration (FDA) approved the second over-the-counter (OTC) naloxone nasal spray product, RiVive (3mg) by non-profit pharmaceutical company Harm Reduction Therapeutics,...
RH
Ryan Hampton
|
July 15, 2023
Believe it or not, an overdose can happen to anyone. Whether you’ve been prescribed pain medication by your doctor, or a loved one is using an illicit substance such as heroin or fentanyl, the risks of an overdose are still present. Several substances that can cause one to...
RH
Ryan Hampton
|
July 01, 2023
Overdose deaths involving illegally manufactured fentanyl laced with xylazine have skyrocketed in recent years, according to the Centers for Disease Control and Prevention (CDC). New CDC data released Thursday showed that between January 2019 and June 2022, the monthly...
RH
Ryan Hampton
|
June 04, 2023
We aren’t the only ones taking this kind of approach. A lab at the University of North Carolina at Chapel Hill runs a mail-based drug-checking program, where people across the country can mail in substances to be tested. And the New York City Department of Health and Mental...
RH
Ryan Hampton
|
April 08, 2023
With four Grammy awards under his belt and tens of millions of records sold, Macklemore has achieved remarkable success in the music industry. His music has been streamed over 13 billion times, solidifying his status as a popular and influential artist. The rapper, whose birth...
RH
Ryan Hampton
|
March 30, 2023
The U.S. Food and Drug Administration on Wednesday approved selling the leading version of naloxone without a prescription, setting the overdose-reversing drug on course to become the first opioid treatment drug to be sold over the counter.